1.北京市和平里医院眼科,北京 100013
2.北京中医药大学东方医院眼科,北京 100078
朱成义,男,45岁,硕士,副主任医师。研究方向:中西医结合诊疗眼表疾病、眼底病及神经眼科疾病。
韦企平,E-mail:wei_dfyy@163.com
扫 描 看 全 文
朱成义, 李冬, 伊琼, 等. 杞菊甘露饮三联疗法治疗肺肾阴虚型阻塞型睑板腺功能障碍相关干眼75例疗效评估[J]. 北京中医药, 2022,41(1):7-11.
Cheng⁃yi ZHU, Dong LI, Qiong YI, et al. Effect evaluation of Qiju Ganlu Yin triple therapy in treating dry eye related to obstructive meibomian gland dysfunction of lung⁃kidney yin deficiency type[J]. Beijing Journal of Traditional Chinese Medicine, 2022,41(1):7-11.
朱成义, 李冬, 伊琼, 等. 杞菊甘露饮三联疗法治疗肺肾阴虚型阻塞型睑板腺功能障碍相关干眼75例疗效评估[J]. 北京中医药, 2022,41(1):7-11. DOI: 10.16025/j.1674-1307.2022.01.002.
Cheng⁃yi ZHU, Dong LI, Qiong YI, et al. Effect evaluation of Qiju Ganlu Yin triple therapy in treating dry eye related to obstructive meibomian gland dysfunction of lung⁃kidney yin deficiency type[J]. Beijing Journal of Traditional Chinese Medicine, 2022,41(1):7-11. DOI: 10.16025/j.1674-1307.2022.01.002.
目的,2,观察杞菊甘露饮治疗肺肾阴虚型轻中度阻塞型睑板腺功能障碍(OMGD)相关干眼的临床效果。,方法,2,采用随机数字表法将150例肺肾阴虚型轻中度OMGD相关干眼的患者分为对照组和观察组各75例。2组均采用0.1%普拉洛芬滴眼液、0.1%玻璃酸钠滴眼液点双眼和睑板腺按摩治疗。同时观察组采用杞菊甘露饮内服和外用熏蒸治疗,而对照组采用蒸馏水熏蒸治疗,2组均治疗4周。对比2组总体疗效及治疗前后眼表疾病指数(OSDI)评分、睑板腺评分、眼红分析、荧光素钠染色评分(FSS)、首次泪膜破裂时间(BUTf)、平均泪膜破裂时间(BUTav)、泪河高度(TMH)及中医证候积分的变化情况。,结果,2,治疗后,观察组的总有效率为90.41%,高于对照组65.75%(,P,<,0.05);观察组的OSDI评分、睑板腺评分、眼红分析、FSS、中医证候积分均较对照组降低(,P,<,0.05),BUTf、BUTav、TMH均提高(,P,<,0.05)。,结论,2,杞菊甘露饮三联疗法可显著改善肺肾阴虚型轻中度OMGD相关干眼患者的主客观症状,补肺益肾、金水相生,恢复肺肾阴阳的平衡状态,促进泪液的分泌,改善眼表的微循环,恢复泪膜的稳态。
Objective,2,To evaluate the clinical effect of“Qiju Ganlu Yin”in treating mild and moderate dry eyes related to obstructive meibomian gland dysfunction (OMGD)of lung-kidney yin deficiency type.,Methods,2,Using a random number table method,150 patients with mild and moderate dry eyes related to OMGD of lung-kidney yin deficiency type were divided into a control group and a treatment group with 75 cases each.Both groups were treated with 0.1 % pranoprofen,0.1 % sodium hyaluronate eye drops for both eyes and meibomian gland massage.Meanwhile,the treatment group was also given Qiju Ganlu Yin for oral taking and external fumigation,while the control group was fumigated with distilled water.Patients of two groups had 4 weeks of treatment.Then,the overall efficacy,ocular surface disease index(OSDI)score,meibomian gland score,ocular red analysis, fluorescein stain score(FSS),first tear film break-up time(TBUTf),average tear film break-up time(BUTav),lower tear meniscus height(TMH)and TCM syndrome score were observed and analyzed.,Results,2,After treatment,the total effective rate in the treatment group was 90.41 %,which was significantly higher than 65.75 % in the control group(,P,<,0.05).Compared with the control group,OSDI score,the meibomian gland score,eye red analysis,FSS and traditional Chinese medicine(TCM)syndrome score in the treatment group were significantly reduced(,P,<,0.05),while the BUTf,BUTav and TMH in the treatment group were significantly increased(,P,<,0.05).,Conclusion,2,Qiju Ganlu Yin triple therapy can significantly improve the subjective and objective symptoms of mild and moderate dry eye in patients related to OMGD of lung-kidney yin deficiency type,invigorate the lung and the kidney,promote the mutual growth of gold and water,restore the balance of yin and Yang in the lung and kidney,promote the secretion of tear,improve the microcirculation of eye surface,and restore the homeostasis of eye surface.
阻塞型睑板腺功能障碍干眼杞菊甘露饮金水相生肺肾阴虚型睑板腺按摩熏蒸
Obstructive meibomian gland dysfunction OMGDdry eyeQiju Ganlu Yinmutual growth of gold and waterlung-kidney yin deficiency typemeibomian gland massagefumigating treatment
TOMLINSON A,BRON AJ,KORB DR,et al.The international workshop on meibomian gland dysfunction:report of the diagnosis subcommittee[J].Invest Ophthalmol Vis Sci,2011,52(4):2006-2049.
孙旭光.睑缘炎与睑板腺功能障碍[M].北京:人民卫生出版社,2015:128-151..
洪晶.我国睑板腺功能障碍诊断与治疗专家共识(2017年)[J].中华眼科杂志,2017,53(9):657-661.
中华医学会眼科学分会角膜病学组.干眼临床诊疗专家共识(2013年)[J].中华眼科杂志,2013,49(1):73-75.
亚洲干眼协会中国分会海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组中国医师协会眼科医师分会眼表与干眼学组.中国干眼专家共识:定义和分类(2020年)[J].中华眼科杂志,2020,6(6):418-422.
WANG MTM,CRAIG JP.Comparative evaluation of clinical methods of tear film stability assessment:a randomized crossover trial[J].JAMA Ophthalmol,2018,136(3):291-294.
BHANDARI V,REDDY JK,RELEKAR K,et al.Non-invasive assessment of tear film stability with a novel corneal topographer in Indian subjects[J].Int Ophthalmol,2016,36(6):781-790.
国家中医药管理局医政司.22个专业95个病种中医诊疗方案[M].北京:中国中医药出版社,2011,6:341-343.
SCHIFFMAN RM,CHRISTIANSON MD,JACOBSEN G,et al.Reliability and validity of the ocular surface disease index[J].Arch Ophthalmol,2000,118(5):615-621.
金明.中医临床诊疗指南释义-眼科疾病分册[M].北京:中国中医药出版社,2015,7:36.
郑玉红,赵国敏.不同中药熏蒸疗法干预蒸发过强型干眼的临床研究[J].北京中医药,2019,38(5):484-487.
郝美玲,夏燕婷,韦企平,等.清热解毒利湿方熏蒸对睑板腺功能障碍相关干眼患者生活质量的影响观察[J].北京中医药,2017,36(8):736-738.
廉海红,支楠.支楠从火及湿热论治睑缘炎经验[J].北京中医药,2021,40(1):63-65.
刘海龙,王钢,王佳,等.基于“金水相生”从“肺肾同治”论治干燥综合征理论探析[J].中医药信息,2019,36(4):39-42.
景大瑞,邢彦仓,姜艳,等.滋水涵木法联合人工泪液治疗干眼症临床疗效观察[J].北京中医药,2016,35(8):720-723.
苏雨辉,孟凡华,曹锦花,等.祛风清热润燥组方超声雾化治疗睑板腺功能障碍的临床研究[J].北京中医药,2016,35(3):253-255.
SRIDHARAN K,SIVARAMAKRISHNAN G.Therapies for meibomian gland dysfunction:a systematic review and meta-analysis of randomized controlled trials[J].Open Ophthalmol J,2017,11:346-354.
BORCHMAN D.The optimum temperature for the heat therapy for meibomian gland dysfunction[J].Ocul Surf,2019,17(2):360-364.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备 11010102006710号